A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension

Status: Terminated
Location: See all (13) locations...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To evaluate the safety and effectiveness of the ROX Coupler used to create an arteriovenous anastomosis in the iliac region (between the iliac artery and vein) in subjects with hypertension.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Maximum Age: 85
Healthy Volunteers: No
View:

• Mean 24-hour ambulatory blood pressure monitoring (ABPM) SBP ≥ 140 mmHg at screening.

Locations
United States
Alabama
Cardiology P.C. Research
Birmingham
UAB Division of Cardiovascular Disease
Birmingham
Florida
The Cardiac and Vascular Institute Research Foundation
Gainesville
Georgia
Piedmont Heart Institute
Atlanta
Illinois
Prairie Education and Research Cooperative
Springfield
Mississippi
Cardiology Associates Research
Tupelo
North Carolina
Duke University Hospital
Durham
New York
Northwell Health - North Shore University Hospital
Manhasset
Northwell Health - Lenox Hill Hospital
New York
Ohio
The Lindner Center for Research and Education at The Christ Hospital
Cincinnati
The MetroHealth System
Cleveland
OhioHealth Research Institute
Columbus
West Virginia
CAMC Clinical Trials Center
Charleston
Time Frame
Start Date: March 22, 2017
Completion Date: May 1, 2019
Participants
Target number of participants: 30
Treatments
Active Comparator: Treatment Group A
ROX Coupler implantation and continuing antihypertensive medications.
Sham Comparator: Control Group B
Sham procedure and continuing current antihypertensive medications.
Related Therapeutic Areas
Sponsors
Leads: ROX Medical, Inc.

This content was sourced from clinicaltrials.gov

Similar Clinical Trials